Joichi Usui

Joichi Usui

Auto-generated profile, based on publicly available information

Joichi Usui

Department of Nephrology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Human Pathology
Verified
Journal Article
Closed access
JUJoichi Usui
Joichi Usui
IGIlya G. Glezerman
Ilya G. Glezerman
SSSteven P. Salvatore
Steven P. Salvatore
CCChandra B. Chandran
Chandra B. Chandran
CFCarlos D. Flombaum
Carlos D. Flombaum
SSSurya V. Seshan
Surya V. Seshan

25 November 2017 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
TKTetsuya Kawamura
Tetsuya Kawamura
JUJoichi Usui
Joichi Usui
SKShuzo Kaneko
Shuzo Kaneko
RTRyoya Tsunoda
Ryoya Tsunoda
EIEri Imai
Eri Imai
KYKunihiro Yamagata
Kunihiro Yamagata
Anaemia is a common complication of patients with antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis. Nevertheless, the cause and degree of such cases of anaemia have not been elucidated in detail. We aimed to investigate the prevalence, cause, pathogenesis of anaemia and the impact of anaemia on prognosis in patients with ANCA-associated renal vasculitis. We identified 45 patients with ANCA-associated renal vasculitis that were clinically and/or histologically diagnosed and treated from 2003 to 2014 at University of Tsukuba Hospital. The relationships between anaemia and various clinicopathological findings were evaluated. At the time of diagnosis of ANCA-associated renal vasculitis, all patients showed anaemia, with a mean haemoglobin level of 7.5 ± 1.3 g/dL. Renal anaemia was diagnosed in 92% of patients, anaemia of chronic disease (ACD) in 56%, and anaemia due to hemorrhage in 20%. Next, the patients were divided into two groups according to anaemia severity: minimum haemoglobin (min Hb) < 7.5 (n = 24) and min Hb ≥ 7.5 (n = 21). A comparison of baseline characteristics showed that serum albumin, maximum serum creatinine, minimum estimated glomerular filtration rate (eGFR), serum cystatin C, and the area of tubulointerstitial damage were significantly different between the haemoglobin groups (p < 0.05). No significant intergroup differences were observed in iron-related or inflammation-related data. With regard to the relationship between anaemia severity and prognosis, patients in the min Hb < 7.5 group tended to have a lower eGFR. Anaemia severity was associated with markedly lower survival (Log-rank test, p = 0.03). In this cohort of patients with ANCA-associated renal vasculitis, all subjects exhibited anaemia. In regard to the cause and pathogenesis, the most prevalent form of anaemia was renal anaemia, not ACD, and a potential reason for the high prevalence of anaemia in our cohort may have been the interaction between renal anaemia and ACD. Moreover, anaemia severity was significantly associated with the degree of renal dysfunction and life prognosis.

1 January 2003 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MNMichio Nagata
Michio Nagata
STShinsuke Tomari
Shinsuke Tomari
KKKatsuyoshi Kanemoto
Katsuyoshi Kanemoto
JUJoichi Usui
Joichi Usui
KLKevin V. Lemley
Kevin V. Lemley

19 October 2010 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
KSKentaro Sakai
Kentaro Sakai
NMNaoki Morito
Naoki Morito
JUJoichi Usui
Joichi Usui
MHMasahiro Hagiwara
Masahiro Hagiwara
AHAkio Hiwatashi
Akio Hiwatashi
KYKunihiro Yamagata
Kunihiro Yamagata
Human hepatitis B virus (HBV) is well known as a cause of membranous nephropathy (MN). While the association of HBV infection with MN is strong, data regarding its association with other glomerular diseases are conflicting. Here, we report a case of focal segmental glomerulosclerosis (FSGS) with HBV infection. In this case, we have found HBV-DNA in urinary podocytes by real-time PCR methods. After the administration of anti-viral therapy, FSGS improved, paralleling the decreased level of HBV-DNA in podocytes. The refractory FSGS induced by HBV could be effectively treated with appropriate anti-viral agents.

28 January 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KNKazuyuki Noguchi
Kazuyuki Noguchi
JIJunji Ishida
Junji Ishida
JKJun-Dal Kim
Jun-Dal Kim
NMNaoto Muromachi
Naoto Muromachi
KKKoichiro Kako
Koichiro Kako
AFAkiyoshi Fukamizu
Akiyoshi Fukamizu
Heart failure and chronic kidney disease are major causes of morbidity and mortality internationally. Although these dysfunctions are common and frequently coexist, the factors involved in their relationship in cardiorenal regulation are still largely unknown, mainly due to a lack of detailed molecular targets. Here, we found the increased plasma histamine in a preclinical mouse model of severe cardiac dysfunction, that had been cotreated with angiotensin II (Ang II), nephrectomy, and salt (ANS). The ANS mice exhibited impaired renal function accompanied with heart failure, and histamine depletion, by the genetic inactivation of histidine decarboxylase in mice, exacerbated the ANS-induced cardiac and renal abnormalities, including the reduction of left ventricular fractional shortening and renal glomerular and tubular injuries. Interestingly, while the pharmacological inhibition of the histamine receptor H3 facilitated heart failure and kidney injury in ANS mice, administration of the H3 agonist immethridine (Imm) was protective against cardiorenal damages. Transcriptome analysis of the kidney and biochemical examinations using blood samples illustrated that the increased inflammation in ANS mice was alleviated by Imm. Our results extend the pharmacological use of H3 agonists beyond the initial purposes of its drug development for neurogenerative diseases and have implications for therapeutic potential of H3 agonists that invoke the anti-inflammatory gene expression programming against cardiorenal damages.

10 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JUJoichi Usui
Joichi Usui
TTTakashi Tawara-Iida
Takashi Tawara-Iida
KTKenji Takada
Kenji Takada
IEItaru Ebihara
Itaru Ebihara
AUAtsushi Ueda
Atsushi Ueda
KYKunihiro Yamagata
Kunihiro Yamagata
The incidence of post-infectious glomerulonephritis (PIGN) in developed countries has decreased over the last 50 years. Here we identified the trends of the incidence of PIGN in Japan during the past four decades. We explored the frequency, clinicopathological findings, and prognosis of PIGN based on 6,369 cases from the Renal Biopsy Database of our institute in the Kanto region of Japan, diagnosed histologically from 1976 to 2009. The numbers of PIGN cases were 131 (2.1%) in total, and 2.4%, 1.1%, 2.6% and 2.1% identified in the 1970s, 1980s, 1990s, and 2000s, respectively. Acute glomerulonephritis (AGN), including post-streptococcal glomerulonephritis (PSGN), accounted for almost all of the PIGN cases in the 1970s, but decreased to approx. 40%–50% since the 1990s. In the 1990s, Staphylococcus aureus infection-related nephritis (SARN) showed a rapid increase in rate, reaching 30%. The incidence of hepatitis C virus infection-associated GN (HCVGN) has increased since the 1990s. The average age at onset rose from 33 to 51 years over the study period. These transitions can be summarized as increases in SARN and HCVGN and decreases in PSGN and other types of AGN, since SARN and HCVGN have older onsets compared to PSGN and other AGN types. The clinicopathological features were marked for each PIGN. Regarding the prognosis, the renal death rates of both the SARN and HCVGN groups were significantly higher than those of other PIGN. Based on our analysis of the Renal Biopsy Database, the incidence of PIGN in Japan reached its peak in the 1990s. The temporal changes in the incidence of PIGN reflected the trends in infectious diseases of each decade and the continual aging of the population, with a related higher susceptibility to infections.